Maharishi Ayurveda Launches AyurDefence-AV

Maharishi Ayurveda today announced the expansion of its Ayurvedic Healthcare portfolio with the launch of its 100% Ayurvedic product AyurDefence-AV amidst the COVID-19 pandemic. This is completely a herbal product made up of the combination of 19 herbs, possessing functional attributes of turning out to be the armour against viral infection & seasonal flu. It has the property to enhance the body’s innate intelligence, which works synergistically for more vitality, inner strength, stability and balance to strengthen immunity.Announcing the launch, Maharishi Ayurveda Chairman, Mr Anand Shrivastava, said, “Given the COVID-19 pandemic situation, we are passing through the age of infection wherein protecting ourselves from this is utmost important for survival. In such a situation, recognising the non-availability of medicines for curing viral infections, and realising the fact that firstly not all the population gets infected, whilst most of those who do get infected also recoup, excepting a few who pass-away, we have launched this product, which is the need of the hour.AyurDefence-AV is made up of 19 herbs, which help the body to combat the viral infection and flu-like symptoms e.g. fever, runny nose, difficulty in breathing, cough, headache, stiffness. The synergistic effect of the herbs in it also helps the body to strengthen its immunity. As AyurDefence-AV is a combination of well-known, highly effective herbs like — Tulsi, Kali Mirch (Piper Nigrum), Ginger, Long pepper, Cumin, Licorice, Bilva ,Giloy, Sonth, Pippali, Mulethi and Lahsun. And these herbs have the characteristics to strengthen the body’s guard against any external health threats including bacterial and viral infection.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!